Russell Frank Company’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$1.4M Buy
116,347
+32,382
+39% +$382K ﹤0.01% 2024
2015
Q4
$1.2M Buy
83,965
+62,407
+289% +$824K ﹤0.01% 2119
2015
Q3
$252K Sell
21,558
-81,296
-79% -$1.22M ﹤0.01% 2655
2015
Q2
$1.81M Buy
102,854
+88,383
+611% +$1.38M ﹤0.01% 2033
2015
Q1
$216K Buy
+14,471
New +$193K ﹤0.01% 2630

Other funds holding AMPH

Russell Frank Company's AMPH Position: Q1 2016 in Review

Russell Frank Company increased its Amphastar Pharmaceuticals (AMPH) stake by 39% in Q1 2016, buying an estimated $382K and bringing the position to 116,347 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2024.

Russell Frank Company first reported a position in AMPH in Q1 2015 and has held it in 5 quarters since. The position peaked at $1.81M in Q2 2015. 95 funds tracked by Wall St. Rank hold AMPH as of Q1 2016.

  • Russell Frank Company held 116,347 shares of Amphastar Pharmaceuticals worth $1.4M as of Q1 2016.
  • Russell Frank Company bought 32,382 Amphastar Pharmaceuticals shares in Q1 2016, an estimated $382K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2024 holding.
  • Russell Frank Company first reported a position in Amphastar Pharmaceuticals in Q1 2015 and has held it in 5 quarters since.
  • Russell Frank Company's Amphastar Pharmaceuticals position peaked at $1.81M in Q2 2015.
  • 95 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.